Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Vilain

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 7, 2015
Histological pattern of Merkel cell carcinoma sentinel lymph node metastasis improves stratification of Stage III patientsJennifer S Ko, Victor G Prieto, Paul J Elson, et al.
Lung Cancer (Amsterdam, Netherlands)|May 31, 2015
PD-L1 expression is a favorable prognostic factor in early stage non-small cell carcinomaWendy A Cooper, Thang Tran, Ricardo E Vilain, et al.
Journal of Cutaneous Pathology|December 30, 2016
5-Hydroxymethylcytosine is a nuclear biomarker to assess biological potential in histologically ambiguous heavily pigmented melanocytic neoplasmsJonathan J Lee, Ricardo E Vilain, Scott R Granter, et al.
Pathology|October 31, 2015
Tumour procurement, DNA extraction, coverage analysis and optimisation of mutation-detection algorithms for human melanoma genomesJames S Wilmott, Matthew A Field, Peter A Johansson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2017
Dynamic Changes in PD-L1 Expression and Immune Infiltrates Early During Treatment Predict Response to PD-1 Blockade in MelanomaRicardo E Vilain, Alexander M Menzies, James S Wilmott, et al.
American Journal of Human Genetics|June 13, 1998
DAX1 mutations map to putative structural domains in a deduced three-dimensional modelY H Zhang, W Guo, R L Wagner, et al.
Nature|May 4, 2017
Whole-genome landscapes of major melanoma subtypesNicholas K Hayward, James S Wilmott, Nicola Waddell, et al.
Pathology|December 23, 2021
BRAF mutation testing for patients diagnosed with stage III or stage IV melanoma: practical guidance for the Australian settingRichard A Scolyer, Victoria Atkinson, David E Gyorki, et al.
The Journal of Clinical Investigation|February 6, 2024
PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine gliomaRyan J Duchatel, Evangeline R Jackson, Sarah G Parackal, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 7, 2015
Histological pattern of Merkel cell carcinoma sentinel lymph node metastasis improves stratification of Stage III patientsJennifer S Ko, Victor G Prieto, Paul J Elson, et al.
Lung Cancer (Amsterdam, Netherlands)|May 31, 2015
PD-L1 expression is a favorable prognostic factor in early stage non-small cell carcinomaWendy A Cooper, Thang Tran, Ricardo E Vilain, et al.
Journal of Cutaneous Pathology|December 30, 2016
5-Hydroxymethylcytosine is a nuclear biomarker to assess biological potential in histologically ambiguous heavily pigmented melanocytic neoplasmsJonathan J Lee, Ricardo E Vilain, Scott R Granter, et al.
Pathology|October 31, 2015
Tumour procurement, DNA extraction, coverage analysis and optimisation of mutation-detection algorithms for human melanoma genomesJames S Wilmott, Matthew A Field, Peter A Johansson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2017
Dynamic Changes in PD-L1 Expression and Immune Infiltrates Early During Treatment Predict Response to PD-1 Blockade in MelanomaRicardo E Vilain, Alexander M Menzies, James S Wilmott, et al.
American Journal of Human Genetics|June 13, 1998
DAX1 mutations map to putative structural domains in a deduced three-dimensional modelY H Zhang, W Guo, R L Wagner, et al.
Nature|May 4, 2017
Whole-genome landscapes of major melanoma subtypesNicholas K Hayward, James S Wilmott, Nicola Waddell, et al.
Pathology|December 23, 2021
BRAF mutation testing for patients diagnosed with stage III or stage IV melanoma: practical guidance for the Australian settingRichard A Scolyer, Victoria Atkinson, David E Gyorki, et al.
The Journal of Clinical Investigation|February 6, 2024
PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine gliomaRyan J Duchatel, Evangeline R Jackson, Sarah G Parackal, et al.
Pageof 7